Venus Remedies Renews GMP Certification in Ukraine, Boosting Global Expansion
Venus Remedies has successfully renewed its GMP certification from Ukraine's SMDC, covering its Baddi manufacturing facility. This certification strengthens their presence in Ukraine and aids penetration into PIC/S markets. Ukraine's pharmaceutical market is projected to grow, driven by generics and oncology demands.
- Country:
- India
Venus Remedies, a leading pharmaceutical company, announced the successful renewal of its good manufacturing practices (GMP) certification from Ukraine's State Service on Medicines and Drugs Control (SMDC) on Saturday.
The certification covers the company's Unit-II manufacturing facility in Baddi, Himachal Pradesh, which produces cephalosporin, non-cephalosporin (carbapenem), and oncology parenteral products, including liquid and lyophilized injections.
With this renewed certification, Venus Remedies strengthens its position in the Ukrainian market and opens doors to the wider Pharmaceutical Inspection Co-operation Scheme (PIC/S) markets, amplifying their international growth prospects.
ALSO READ
-
Naftogaz Sets Out Cleaner Energy Future With EIB Support and 2050 Net Zero Target
-
KSrelief and UNDP Launch $5M Lifeline for Ukraine’s War-Affected Hospitals
-
Poltava University Reopens With Safer, Greener Spaces for Nearly 3,000 Campus Users
-
UNDP Urges Recovery From Day One as 160 Million People Risk Being Trapped in Crisis
-
Ukraine Faces Another Bitter Winter as UN Inquiry Warns of Deepening Civilian Harm
Google News